Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FS5ZS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,278
Award facts
- Contract value 100% obligated
- $79,278.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $79,278.21 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed-price contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The place of performance is the company's corporate office in Conshohocken, Pennsylvania. As a child contract under the larger IDC vehicle, this delivery order enables the federal government to procure critical pharmaceutical commodities to support military healthcare programs and Defense Health Agency operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds an extensive portfolio of federal contracts with the DLA, including a significant $999,999,999 IDC running through December 2026 that serves as the comprehensive vehicle for this Menveo vaccine delivery. The company's federal procurement activities demonstrate consistent capability in supplying a broad range of pharmaceutical products, medical devices, and vaccines across multiple therapeutic domains to support military and veteran healthcare systems. This vaccine delivery fulfills critical medical supply needs within DLA's pharmaceutical prime vendor program, which supports global military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FS5ZS?
SPE2DB25FS5ZS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FS5ZS worth?
The government has obligated $79,278 on SPE2DB25FS5ZS.
Is contract SPE2DB25FS5ZS an order under another contract?
Yes. SPE2DB25FS5ZS is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS5ZS competed?
The extent of competition for SPE2DB25FS5ZS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award